2008
DOI: 10.1016/s1098-3015(10)66993-8
|View full text |Cite
|
Sign up to set email alerts
|

Pss1 Risk of Psychiatric Disorders and Health Care Expenditures Among Patients With Moderate to Severe Psoriasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
57
0
1

Year Published

2012
2012
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 36 publications
(62 citation statements)
references
References 0 publications
4
57
0
1
Order By: Relevance
“…Psoriasis has multiple possible causes, and medical professionals should pay additional attention to recognize all contributing factors of this disease (2,3). It is shown that the prevalence of psychiatric disorders is higher in patients with moderate-to-severe psoriasis (4). Suicide and its related death is higher among these patients (5).…”
mentioning
confidence: 99%
“…Psoriasis has multiple possible causes, and medical professionals should pay additional attention to recognize all contributing factors of this disease (2,3). It is shown that the prevalence of psychiatric disorders is higher in patients with moderate-to-severe psoriasis (4). Suicide and its related death is higher among these patients (5).…”
mentioning
confidence: 99%
“…Eczema and psoriasis are seen each in 0.5 % of BD patients which is roughly double of what expected in the general population (Weber et al 2011 ). From a reverse angle, patients with psoriasis have double rates of BD (1.1 % vs. 0.5 %), in comparison to controls (Han et al 2011 ).…”
Section: Dermatological Disordersmentioning
confidence: 75%
“…It has been observed that the prevalence of anxiety, depression, bipolar disorder or delirium is higher in psoriatic patients than controls. The proportion of patients receiving antidepressants, anxiolytics or antipsychotics was higher in psoriatic patients than controls [26]. In fact, the average total yearly health care cost for psoriasis patients (US $11,369) was significantly higher than for controls ($3,427), placing a large economic burden on patients and the healthcare system.…”
Section: Psoriasis and Co-morbiditiesmentioning
confidence: 99%